By integrating GLP-1 medications into your weight loss program, Cape Fear Physical Medicine and Rehab provides effective tools to help you achieve and maintain a healthier weight and improve your overall well-being
Via several processes, including insulin and leptin resistance, perivascular adipose tissue dysfunction, reduced kidney function, activation of the renin-angiotensin-aldosterone system, and increased sympathetic nervous system activity, obesity can cause hypertension
14 According to our patent searches, Novo Nordisk has filed 91 patents for formulations, 41 patents covering devices to deliver the drug, and 45 patents for methods of treatment (Figure 6)
should be considered before using GLP-1
Key Findings Zepbound users noted hypertension concerns: Hypertension appeared more frequently in discussions of this newer tirzepatide brand (0.73% of posts)
Retatrutide is an investigational, longacting triple agonist targeting GLP1, GIP, and glucagon receptors